Protagonist Therapeutics, Inc. PTGX announced that the FDA has granted an orphan drug designation to its injectable hepcidin mimetic PTG-300 for the treatment of polycythemia vera. The candidate ...

'Forrest Gump' producer Wendy Finerman and 'American Ninja Warrior' host Matt Iseman are judging a short film comp centered on Posttraumatic Growth.

PTG-007 administration resulted in improved remission and insulin secretion Patients monitored for up to 12 years Planned pivotal Phase 2/3 study is final step for PolTREG to bring PTG-007 to ...

Protagonist had recently announced initial positive Phase II results of PTG-300 in patients with polycythemia vera. The stock is currently trading at $17.92, close to its 52-week high of $18.70.